Latest Trials

EudraCT Number: 2006-004516-51

Sponsor Protocol Number: GEN112

Start Date: 2006-11-20

Sponsor Name: Genmab A/S

Full Title: A multicentre open-label, dose-escalation, trial of zanolimumab in combination with CHOP chemotherapy in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement

Medical condition: CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10034624	Peripheral T-cell lymphoma unspecified NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Prematurely Ended) DE (Completed) IT (Prematurely Ended)

Trial results: View results

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions